EpViX: A cloud-based tool for epitope reactivity analysis and epitope virtual crossmatching to identify low immunologic risk donors for sensitized recipients.
暂无分享,去创建一个
Adalberto Socorro da Silva | Semiramis Jamil Hadad do Monte | Fernando Antonio Costa Anunciação | Luiz Claudio Demes da Mata Sousa | Mário Sérgio Coelho Marroquim | Antônio Gilberto Borges Coelho | Glauco Henrique Willcox | João Marcelo Medeiros de Andrade | Bruno de Melo Corrêa | Elisabeth Lima Guimarães | S. J. H. do Monte | L. C. D. Sousa | A. S. da Silva | M. S. Marroquim | G. Willcox | Fernando Antônio Costa Anunciação | Antônio Gilberto B. Coelho | J. D. de Andrade | A. Da Silva
[1] R. Duquesnoy,et al. HLAMatchmaker: a molecularly based algorithm for histocompatibility determination. II. Verification of the algorithm and determination of the relative immunogenicity of amino acid triplet-defined epitopes. , 2002, Human immunology.
[2] A. Laupacis,et al. Immune Sensitization and Mortality in Wait-Listed Kidney Transplant Candidates. , 2016, Journal of the American Society of Nephrology : JASN.
[3] M. Marrari,et al. 16th IHIW: A Website for Antibody‐Defined HLA Epitope Registry , 2012, International journal of immunogenetics.
[4] I. Doxiadis,et al. HLAmatchmaker: a molecularly based algorithm for histocompatibility determination. III. Effect of matching at the HLA-A,B amino acid triplet level on kidney transplant survival1 , 2003, Transplantation.
[5] D. Roelen,et al. THE NUMBER OF AMINO ACID TRIPLET DIFFERENCES BETWEEN PATIENT AND DONOR IS PREDICTIVE FOR THE ANTIBODY REACTIVITY AGAINST MISMATCHED HUMAN LEUKOCYTE ANTIGENS1 , 2004, Transplantation.
[6] L. Sharples,et al. Ten-Year Experience of Selective Omission of the Pretransplant Crossmatch Test in Deceased Donor Kidney Transplantation , 2010, Transplantation.
[7] A. Rahmel,et al. Enhanced kidney allocation to highly sensitized patients by the acceptable mismatch program. , 2009, Transplantation.
[8] S. J. H. do Monte,et al. First report on the antibody verification of HLA-DR, HLA-DQ and HLA-DP epitopes recorded in the HLA Epitope Registry. , 2014, Human immunology.
[9] M. Melcher,et al. Center‐Defined Unacceptable HLA Antigens Facilitate Transplants for Sensitized Patients in a Multi‐Center Kidney Exchange Program , 2014, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[10] Pedro de Alcântara dos Santos Neto,et al. EpHLA: an innovative and user-friendly software automating the HLAMatchmaker algorithm for antibody analysis. , 2011, Transplant immunology.
[11] S. J. H. do Monte,et al. First report on the antibody verification of HLA-ABC epitopes recorded in the website-based HLA Epitope Registry. , 2014, Tissue antigens.
[12] D. Roelen,et al. Immunogenetics and immunology of transplantation in Leiden. , 2014, Transplant immunology.
[13] René J Duquesnoy,et al. HLAMatchmaker: a molecularly based algorithm for histocompatibility determination. I. Description of the algorithm. , 2002, Human immunology.
[14] I. Doxiadis,et al. The acceptable mismatch program as a fast tool for highly sensitized patients awaiting a cadaveric kidney transplantation: short waiting time and excellent graft outcome. , 2004, Transplantation.
[15] R. Duquesnoy. HLAMMATCHMAKER: a molecularly based donor selection algorithm for highly alloimmunized patients. , 2001, Transplantation proceedings.
[16] P W Nickerson,et al. Class II HLA Epitope Matching—A Strategy to Minimize De Novo Donor‐Specific Antibody Development and Improve Outcomes , 2013, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[17] Herton Luiz Alves Sales Filho,et al. EpHLA software: a timesaving and accurate tool for improving identification of acceptable mismatches for clinical purposes. , 2012, Transplant immunology.
[18] A. S. Silva,et al. First report on the antibody verification of MICA epitopes recorded in the HLA epitope registry , 2014, International journal of immunogenetics.